Dr. Shilpa Gupta describes the basics of cancer clinical trials, including the possible risks and benefits that they offer.

Lung cancer affects tens of thousands of Americans every year. In this blog post, Cancer.Net Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.

Cancer affects many people as they grow older, so it’s important to have scientific research that focuses on older adults. Dr. Stuart Lichtman discusses why studies haven’t focused on older adults in the past and what is being done to change that.

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community.

Neal Meropol, MD, FASCO, discusses the various segments, or “phases,” that mark clinical trials.

Susan Cohn, MD, shares a personal story about the courage of parents who enrolled their child in a clinical trial for a drug that is now approved to treat neuroblastoma.

Edward S. Kim, MD, FACP, shares new approaches to molecular medicine that are helping doctors to better treat patients with cancer.

In this podcast, Leslie R. Schover, PhD, discusses the sexual concerns that often come with hormone therapy for prostate cancer.

Patient advocate Diana Chingos wanted to attend the 2015 ASCO Annual Meeting to learn about the latest cancer research. After four intense days of posters and presentations, she left Chicago with a mountain of new knowledge and four key insights.

In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.